Pallas Capital Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-39,036
Closed -$446K 982
2025
Q4
$446K Sell
39,036
-43,485
-53% -$510K 0.01% 570
2025
Q3
$1.05M Buy
82,521
+350
+0.4% +$5.08K 0.04% 338
2025
Q2
$1.3M Buy
82,171
+37,306
+83% +$558K 0.05% 271
2025
Q1
$670K Buy
44,865
+30,953
+222% +$548K 0.03% 390
2024
Q4
$264K Buy
+13,912
New +$294K 0.01% 495

Other funds holding XRAY

Pallas Capital Advisors's XRAY Position: Q1 2026 in Review

Pallas Capital Advisors sold out of Dentsply Sirona (XRAY) in Q1 2026, closing a stake of 39,036 shares — an estimated $446K sold.

Pallas Capital Advisors first reported a position in XRAY in Q4 2024 and held it in 5 quarters. The position peaked at $1.3M in Q2 2025. 384 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Pallas Capital Advisors reported no remaining Dentsply Sirona position as of Q1 2026 after selling out during the quarter.
  • Pallas Capital Advisors sold 39,036 Dentsply Sirona shares in Q1 2026, an estimated $446K.
  • Pallas Capital Advisors first reported a position in Dentsply Sirona in Q4 2024 and held it in 5 quarters.
  • Pallas Capital Advisors's Dentsply Sirona position peaked at $1.3M in Q2 2025.
  • 384 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.